Legal status · United States
Is Elamipretide legal in the United States?
Yes. Elamipretide is an approved medicine in the United States, classified as "FDA-approved (Forzinity, Barth syndrome only), prescription only; other uses investigational". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Moderate.
Elamipretide in the United States at a glance
| Classification | FDA-approved (Forzinity, Barth syndrome only), prescription only; other uses investigational |
|---|---|
| FDA approval status | FDA-approved September 19, 2025 as Forzinity (accelerated approval) for Barth syndrome; other uses investigational |
| Evidence level | Moderate (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Elamipretide profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Elamipretide for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Elamipretide is
An investigational mitochondria-targeting peptide studied for rare mitochondrial disease and age-related organ decline.
Elamipretide concentrates in the inner mitochondrial membrane by binding cardiolipin, aiming to restore efficient energy production. It has been studied in clinical trials for primary mitochondrial myopathy, Barth syndrome, and dry age-related macular degeneration, with mixed results.
Mechanism: Binds cardiolipin in the inner mitochondrial membrane, stabilizing cristae structure and improving electron transport efficiency and ATP production.
Regulatory history: FDA-approved September 19, 2025 as Forzinity (accelerated approval) for Barth syndrome; other uses investigational
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Elamipretide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Elamipretide in other countries
Frequently asked questions
Is Elamipretide legal in the United States?
Yes. Elamipretide is an approved medicine in the United States, classified as "FDA-approved (Forzinity, Barth syndrome only), prescription only; other uses investigational". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Moderate.
Can I buy Elamipretide in the United States?
Only with a prescription. Elamipretide is classified as "FDA-approved (Forzinity, Barth syndrome only), prescription only; other uses investigational" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Elamipretide FDA approved?
Yes. FDA status: FDA-approved September 19, 2025 as Forzinity (accelerated approval) for Barth syndrome; other uses investigational. Current US classification: "FDA-approved (Forzinity, Barth syndrome only), prescription only; other uses investigational". Evidence level: Moderate.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Elamipretide live on its compound profile.
Elamipretide profileThis page is general information about the regulatory status of Elamipretide in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.